Phase-I study of Innacell γδTM, an autologous cell-therapy product highly enriched in γ9δ2 T lymphocytes, in combination with IL-2, in patients with metastatic renal cell carcinoma

Bibliographische Detailangaben

Veröffentlicht in:	Cancer immunology and immunotherapy 2008, Vol.57 (11), p.1599-1609
Hauptverfasser:	BENNOUNA, Jaafar, BOMPAS, Emmanuelle, LAFAYE-DE MICHEAUX, Sylvie, TIOLLIER, Jerome, NEGRIER, Sylvie, NEIDHARDT, Eve Marie, ROLLAND, Frederic, PHILIP, Irène, GALEA, Celine, SALOT, Samuel, SAIAGH, Soraya, AUDRAIN, Marie, RIMBERT, Marie
Format:	Artikel
Sprache:	eng
Schlagworte:	Antineoplastic agents Biological and medical sciences Immunotherapy Kidneys Medical sciences Nephrology. Urinary tract diseases Pharmacology. Drug treatments Tumors of the urinary system
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!